Figure 5 | British Journal of Cancer

Figure 5

From: A comparative study between catalase gene therapy and the cardioprotector monohydroxyethylrutoside (MonoHER) in protecting against doxorubicin-induced cardiotoxicity in vitro

Figure 5

Beating rate of NeRCaMs within 3 days of treatment with different concentrations of doxorubicin (–♦– ) with(out) preinfection with AdCat (MOI 50) (⋯◊⋯) or cotreatment with 1 mM monoHER (–◊–). The P-values, which indicate significant protection against doxorubicin effect, were calculated by the ANOVA of multiple regression of ln (beating rate) vs ln doxorubicin concentration alone, with 1 mM monoHER or with AdCat (MOI 50) preinfection.

Back to article page